Literature DB >> 20377753

Plasma lipoproteins are important components of the immune system.

Runlin Han1.   

Abstract

Plasma lipoproteins (VLDL, LDL, Lp[a] and HDL) function primarily in lipid transport among tissues and organs. However, cumulative evidence suggests that lipoproteins may also prevent bacterial, viral and parasitic infections and are therefore a component of innate immunity. Lipoproteins can also detoxify lipopolysaccharide and lipoteichoic acid. Infections can induce oxidation of LDL, and oxLDL in turn plays important anti-infective roles and protects against endotoxin-induced tissue damage. There is also evidence that apo(a) is protective against pathogens. Taken together, the evidence suggests that it might be valuable to introduce the concept that plasma lipoproteins belong in the realm of host immune response.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20377753     DOI: 10.1111/j.1348-0421.2010.00203.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  25 in total

Review 1.  Functional primate genomics--leveraging the medical potential.

Authors:  Wolfgang Enard
Journal:  J Mol Med (Berl)       Date:  2012-05-04       Impact factor: 4.599

2.  Apolipoprotein(a) inhibits lipopolysaccharide-induced IL-6 secretion in human astrocytoma cell line by interfering with lipopolysaccharide signaling.

Authors:  Guglielmina Chimienti; Anna Mezzapesa; Grazia M Liuzzi; Tiziana Latronico; Gabriella Pepe
Journal:  Inflamm Res       Date:  2010-11-02       Impact factor: 4.575

3.  Associations of lipoproteins with cardiovascular and infection-related outcomes in patients receiving hemodialysis.

Authors:  George A Kaysen; Barbara Grimes; Lorien S Dalrymple; Glenn M Chertow; Julie H Ishida; Cynthia Delgado; Mark Segal; Janet Chiang; Tjien Dwyer; Kirsten L Johansen
Journal:  J Clin Lipidol       Date:  2017-12-27       Impact factor: 4.766

4.  Low LDL-C levels are associated with risk of mortality in a Chinese cohort study.

Authors:  Jie-Ming Lu; Meng-Yin Wu; Zong-Ming Yang; Yao Zhu; Die Li; Zhe-Bin Yu; Peng Shen; Meng-Ling Tang; Ming-Juan Jin; Hong-Bo Lin; Li-Ming Shui; Kun Chen; Jian-Bing Wang
Journal:  Endocrine       Date:  2021-05-14       Impact factor: 3.633

Review 5.  Lipid testing in infectious diseases: possible role in diagnosis and prognosis.

Authors:  Sebastian Filippas-Ntekouan; Evangelos Liberopoulos; Moses Elisaf
Journal:  Infection       Date:  2017-05-08       Impact factor: 3.553

6.  Potential risk factors for nonalcoholic steatohepatitis related to pancreatic secretions following pancreaticoduodenectomy.

Authors:  Sun Choon Song; Seong Ho Choi; Dong Wook Choi; Jin Seok Heo; Woo Seok Kim; Min Jung Kim
Journal:  World J Gastroenterol       Date:  2011-08-28       Impact factor: 5.742

7.  Serum Lipoproteins Are Critical for Pulmonary Innate Defense against Staphylococcus aureus Quorum Sensing.

Authors:  Brett C Manifold-Wheeler; Bradley O Elmore; Kathleen D Triplett; Moriah J Castleman; Michael Otto; Pamela R Hall
Journal:  J Immunol       Date:  2015-11-25       Impact factor: 5.422

Review 8.  The spectrum of statin therapy in cancer patients: is there a need for further investigation?

Authors:  Michael J Gonyeau
Journal:  Curr Atheroscler Rep       Date:  2014-01       Impact factor: 5.113

9.  Statins and COVID-19: To Suspend or Not to Suspend? That is the Question!

Authors:  Filipe Ferrari; Raul D Santos
Journal:  Arq Bras Cardiol       Date:  2021-01       Impact factor: 2.000

10.  Major Lipids and Future Risk of Pneumonia: 20-Year Observation of the Atherosclerosis Risk in Communities (ARIC) Study Cohort.

Authors:  Sangmee Sharon Bae; L Cindy Chang; Sharon Stein Merkin; David Elashoff; Junichi Ishigami; Kunihiro Matsushita; Christina Charles-Schoeman
Journal:  Am J Med       Date:  2020-08-16       Impact factor: 4.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.